Old Web
English
Sign In
Acemap
>
authorDetail
>
Manoel Neves
Manoel Neves
Bayer Corporation
Copanlisib
Aggressive lymphoma
Medicine
Phosphatidylinositol
Cancer research
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 2a study of the phosphatidylinositol-3-kinase (PI3K) inhibitor copanlisib in patients with relapsed/refractory, indolent or aggressive lymphoma
2016
Onkologie
Martin Dreyling
Franck Morschhauser
Kamal Bouabdallah
David Cunningham
D. Bron
Kim Linton
Sarit Assouline
Gregor Verhoef
Catherine Thieblemont
U. Vitolo
J. Garcia-Vargas
Igor Gorbatchevsky
Manoel Neves
Julia Grunert
Florian Hiemeyer
Barrett H. Childs
P. L. Zinzani
Show All
Source
Cite
Save
Citations (0)
PHASE 2A STUDY OF THE PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR COPANLISIB IN PATIENTS WITH RELAPSED/REFRACTORY, INDOLENT OR AGGRESSIVE LYMPHOMA. P318, 2016: Non-Hodgkin & Hodgkin lymphoma - Novel agents
2016
Martin Dreyling
Franck Morschhauser
Krimo Bouabdallah
David Cunningham
Dominique Bron
Kim Linton
Sarit Assouline
Gregor Verhoef
Catherine Thieblemont
U. Vitolo
J. Garcia-Vargas
Igor Gorbatchevsky
Manoel Neves
Julia Grunert
Florian Hiemeyer
Barrett H. Childs
Pier Luigi Zinzani
Show All
Source
Cite
Save
Citations (0)
Results of the Mantle Cell Lymphoma Subset from a Phase 2a Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent and Aggressive Lymphoma
2015
Blood
David Cunningham
Pier Luigi Zinzani
Sarit Assouline
Krimo Bouabdallah
Dominique Bron
Corinne Haioun
Luigina Mollica
Marius Giurescu
Igor Gorbatchevsky
Manoel Neves
Marta M. Lemos
Julia Grunert
Florian Hiemeyer
Barrett H. Childs
Martin Dreyling
Show All
Source
Cite
Save
Citations (8)
1